Precise cryosurgical treatment with controlled therapeutic freezing.
The Keeler Cryomatic MK II is an ophthalmic cryotherapy system designed to deliver controlled freezing therapy for retinal and anterior segment procedures. It provides accurate temperature regulation and reliable probe performance for safe and effective cryosurgical treatment.
The Keeler Cryomatic MK II Cryotherapy Unit is developed for ophthalmic cryosurgery where precise freezing is required to treat specific eye conditions. The device works by delivering extremely low temperatures through a specialized probe, creating localized therapeutic freezing that seals or destroys targeted tissue while minimizing damage to surrounding structures.
The unit allows clinicians to control freezing intensity and duration, ensuring consistent treatment outcomes. Various interchangeable cryoprobes support different clinical applications, and the system’s stable temperature control helps maintain predictable cryo-adhesion. Its ergonomic controls and compact console design make it suitable for use in ophthalmic operating rooms and specialized eye clinics. The Cryomatic MK II is commonly used in retinal procedures such as retinal tear repair and certain anterior segment treatments.
Key Features
Q1. What is the purpose of the Cryomatic MK II?
It provides controlled freezing (cryotherapy) to treat specific eye conditions during ophthalmic procedures.
Q2. How does cryotherapy help retinal disease?
Freezing creates a controlled scar that seals retinal tears and helps prevent retinal detachment.
Q3. Is the procedure invasive?
Cryotherapy is considered minimally invasive compared with open surgical techniques.
Q4. Who uses the Cryomatic MK II?
It is primarily used by ophthalmologists and retinal surgeons.
Q5. Where is the system typically installed?
It is used in ophthalmic operating rooms, eye hospitals, and specialized eye clinics.
